ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-κB via phosphoinosotide remodeling of endosomes

[1]  N. Gerges,et al.  BRAG1/IQSEC2 as a regulator of small GTPase-dependent trafficking , 2020, Small GTPases.

[2]  Å. Gustafsson,et al.  Isolation of Rab5-positive endosomes reveals a new mitochondrial degradation pathway utilized by BNIP3 and Parkin , 2020, Small GTPases.

[3]  C. Farrar,et al.  Complement Recognition Pathways in Renal Transplantation. , 2017, Journal of the American Society of Nephrology : JASN.

[4]  J. Pober,et al.  Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells , 2017, Nature Communications.

[5]  C. Bayly-Jones,et al.  The mystery behind membrane insertion: a review of the complement membrane attack complex , 2017, Philosophical Transactions of the Royal Society B: Biological Sciences.

[6]  J. Pober,et al.  Complement C5 Inhibition Reduces T Cell–Mediated Allograft Vasculopathy Caused by Both Alloantibody and Ischemia Reperfusion Injury in Humanized Mice , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[7]  B. Morgan,et al.  The membrane attack complex as an inflammatory trigger. , 2016, Immunobiology.

[8]  D. Goldstein,et al.  Innate immune mechanisms in transplant allograft vasculopathy , 2016, Current opinion in organ transplantation.

[9]  P. Tak,et al.  Nuclear Factor-κB–inducing Kinase Is Expressed in Synovial Endothelial Cells in Patients with Early Arthritis and Correlates with Markers of Inflammation: A Prospective Cohort Study , 2015, The Journal of Rheumatology.

[10]  Rebecca Liu,et al.  Complement membrane attack complexes activate noncanonical NF-κB by forming an Akt+NIK+ signalosome on Rab5+ endosomes , 2015, Proceedings of the National Academy of Sciences.

[11]  K. Okkenhaug,et al.  PI3K inhibitors in inflammation, autoimmunity and cancer , 2015, Current opinion in pharmacology.

[12]  P. De Camilli,et al.  Detection and manipulation of phosphoinositides. , 2015, Biochimica et biophysica acta.

[13]  L. Joshua-Tor,et al.  PTEN functions by recruitment to cytoplasmic vesicles. , 2015, Molecular cell.

[14]  J. Pober,et al.  Alloantibody and Complement Promote T Cell–Mediated Cardiac Allograft Vasculopathy Through Noncanonical Nuclear Factor-&kgr;B Signaling in Endothelial Cells , 2013, Circulation.

[15]  T. Balla,et al.  Phosphoinositides: tiny lipids with giant impact on cell regulation. , 2013, Physiological reviews.

[16]  Yi Tang,et al.  A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20 , 2011, Nature Medicine.

[17]  G. Robertson,et al.  The Akt signaling pathway , 2011, Cancer biology & therapy.

[18]  T. Wyss-Coray,et al.  Identification of a central role for complement in osteoarthritis , 2011, Nature Medicine.

[19]  Ari Helenius,et al.  Endosome maturation , 2011, The EMBO journal.

[20]  S. Ghosh,et al.  Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.

[21]  J. Sarkaria,et al.  WWP2 is an E3 ubiquitin ligase for PTEN , 2011, Nature Cell Biology.

[22]  徐涛,et al.  Application of Improved Wavelet Transform in Biological Particle Detection , 2010 .

[23]  Zhang Yong.  Application of Improved Wavelet Transform in Biological Particle Detection , 2010 .

[24]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[25]  P. Pandolfi,et al.  NEDD4-1 Is a Proto-Oncogenic Ubiquitin Ligase for PTEN , 2007, Cell.

[26]  B. McManus,et al.  Allograft Vasculopathy Versus Atherosclerosis , 2006, Circulation research.

[27]  N. Curtin,et al.  Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM , 2004, Cancer Research.

[28]  M. Fishbein,et al.  Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. , 2004, Human immunology.

[29]  J. Wrana,et al.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.

[30]  G. Superti-Furga,et al.  Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. , 2000, Human molecular genetics.

[31]  M. Lindsay,et al.  Localization of phosphatidylinositol 3‐phosphate in yeast and mammalian cells , 2000, The EMBO journal.

[32]  G Tellides,et al.  In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Tavaré,et al.  Confocal imaging of the subcellular distribution of phosphatidylinositol 3,4,5-trisphosphate in insulin- and PDGF-stimulated 3T3-L1 adipocytes. , 1999, The Biochemical journal.

[34]  C. Burd,et al.  Phosphatidylinositol 3-phosphate recognition by the FYVE domain. , 1999, Molecular cell.

[35]  P. Várnai,et al.  Phosphatidylinositol 3-Kinase-dependent Membrane Association of the Bruton’s Tyrosine Kinase Pleckstrin Homology Domain Visualized in Single Living Cells* , 1999, The Journal of Biological Chemistry.

[36]  A. Chawla,et al.  A functional PtdIns(3)P-binding motif , 1998, Nature.

[37]  Rein Aasland,et al.  FYVE fingers bind PtdIns(3)P , 1998, Nature.

[38]  C. Burd,et al.  Phosphatidylinositol(3)-phosphate signaling mediated by specific binding to RING FYVE domains. , 1998, Molecular cell.

[39]  F. McCormick,et al.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. , 1998, Science.

[40]  L. Cantley,et al.  Regulation of GRP1-catalyzed ADP Ribosylation Factor Guanine Nucleotide Exchange by Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.

[41]  M. Zerial,et al.  Rabaptin-5 is a direct effector of the small GTPase Rab5 in endocytic membrane fusion , 1995, Cell.

[42]  D. Salomon,et al.  Origin of cells in the coronary intima during acute vascular rejection of the transplanted human heart. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[43]  P. Libby,et al.  Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. , 1991, The American journal of pathology.

[44]  H. Grunicke,et al.  Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. , 1991, Cancer research.